CN103638072A - Traditional Chinese medicine preparation for treating chronic prostatitis caused by blood-stasis obstructed in interior - Google Patents

Traditional Chinese medicine preparation for treating chronic prostatitis caused by blood-stasis obstructed in interior Download PDF

Info

Publication number
CN103638072A
CN103638072A CN201310608246.2A CN201310608246A CN103638072A CN 103638072 A CN103638072 A CN 103638072A CN 201310608246 A CN201310608246 A CN 201310608246A CN 103638072 A CN103638072 A CN 103638072A
Authority
CN
China
Prior art keywords
parts
blood
stasis
chinese medicine
interior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310608246.2A
Other languages
Chinese (zh)
Inventor
宋爱民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310608246.2A priority Critical patent/CN103638072A/en
Publication of CN103638072A publication Critical patent/CN103638072A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a traditional Chinese medicine preparation for treating chronic prostatitis caused by blood-stasis obstructed in the interior. The preparation is composed of the following raw materials in parts by weight: 2 parts of Chinese mole cricket, 2 parts of semen impatientis, 3 parts of pillbug, and 4 parts of salt cake. The traditional Chinese medicine preparation has the functions of resolving stasis, dissipating binds, and promoting urination, and has the characteristics of rapid effect, good curative effect, no side or toxic effect, external application, and direct action on affected parts.

Description

The Chinese medicine preparation for the treatment of type of blood-stasis obstructing in the interior chronic prostatitis
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of type of blood-stasis obstructing in the interior chronic prostatitis, belong to Chinese medicine technical field.
Background technology
Chronic prostatitis belongs to the difficulty in urination category of Chinese medicine.What the present invention treated is type of blood-stasis obstructing in the interior.Clinical common urine drop and lower or urine thin as line or time close when logical, little distention and fullness in the abdomen and pain, frequent micturition number, nocturia increase, red tongue or have petechia.Its pathogenesis be blood stasis lose essence block in interior or stasis in bulk, block between bladder urethra due to.By dialectical the present invention, having taked clots absorbing eliminating stagnation, tonneau water channel is principle for the treatment of, has obtained good therapeutic effect.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine preparation for the treatment of type of blood-stasis obstructing in the interior chronic prostatitis, there is the effect of clots absorbing eliminating stagnation, tonneau water channel.Have instant effect, curative effect high, have no side effect, the features such as topical administration, through sick institute.
The present invention treats the Chinese medicine preparation of type of blood-stasis obstructing in the interior chronic prostatitis, and the weight of each raw material consists of: 2 parts of Gryllotalpas, 2 parts of Semen Impatientis, 3 parts of Armadillidiums, 4 parts, Natrii Sulfas.
Drug action mechanism in the present invention is as follows:
Gryllotalpa: this product is salty-cold, returns bladder, large intestine, small intestine meridian, and this product has stronger inducing diuresis to remove edema effect.< < Compendium of Materia Medica > > " sharp defecation, control scrofula, bone is choked ".
Semen Impatientis: micro-hardship, temperature, slightly poisonous, this product has the effect of good blood circulation promoting competent silt, eliminating stagnation.
Armadillidium: removing blood stasis disappear crust, diuretic, clinically for diseases such as dysuria, edema.
Natrii Sulfas: this product is salty-cold, its property is fallen and is let out, and has stronger purging heat to relax the bowels, the effect of hard masses softening and resolving.
Armadillidium of the present invention is principal agent, and Gryllotalpa is adjuvant, and Semen Impatientis, Natrii Sulfas are adjuvant.The main pathogenesis of primary disease is that stagnation of blood stasis in prostate, QI-blood circulation are not smooth, stasis blocking compressing urethra causes dysuria.Selecting Armadillidium is principal agent, the one, abolish blood stasis, and the 2nd, its urine of profit, the 3rd, it is warm in nature leads to, enters Liver Channel, adjusts its mechanism of qi.Gryllotalpa is salty-cold, enters bladder, intestine and small intestine warp, has the effect of good relieving stranguria by diuresis, for strengthening the effect of principal agent relieving stranguria by diuresis.Semen Impatientis blood circulation promoting competent silt eliminating stagnation, Natrii Sulfas hard masses softening and resolving, Papillary has been strengthened the effect of repercussive knot, is adjuvant altogether.
The effect of all medicines and cure mainly and be all referred to teaching material < < Chinese materia medica > > above.
Compared with prior art, the present invention has following beneficial effect:
The selected Chinese herbal medicine of the present invention all meets < < Pharmacopoeia of People's Republic of China > > regulation, according to compatibility, the present invention has the effect of clots absorbing eliminating stagnation, tonneau water channel, is mainly used in clinically type of blood-stasis obstructing in the interior chronic prostatitis.
The present invention not only has good therapeutical effect to chronic prostatitis, and can the prostatitic generation of preventing chronic.Prostate fibrosis, urethra reflexive spasm, urine retention are also had to obvious therapeutic effect.
The present invention is a kind of medicine for external use, nontoxic, easy to use, through sick institute.Prescription of the present invention is rigorous, scientific and efficient, instant effect, cure rate are high.
Below for clinical trial is summed up: clinical experiment treatment type of blood-stasis obstructing in the interior chronic prostatitis 200 examples.
Type of blood-stasis obstructing in the interior chronic prostatitis syndrome shape: urine drop and lower or urine thin as line or time close when logical, little distention and fullness in the abdomen and pain, frequent micturition number, nocturia increase, red tongue or have petechia.
Therapeutic scheme: the present invention grinds as fine powder, one time 10 grams with vinegar furnishing pasty state, include in soak cream non-woven fabrics and be pasted into umbilical part, within 24 hours, change dressings once, within 50 days, be a course for the treatment of.
Therapeutic outcome: type of blood-stasis obstructing in the interior patients with chronic prostatitis is after a course of therapy, and recovery from illness 120 examples, account for 60%, and 70 examples that take a turn for the better, account for 35%, and invalid 10 examples, account for 5%, total effective rate 95%.Shown in treatment, without any side effects to patient, three large routine tests and hepatic and renal function detect, no abnormal.
Treatment standard:
Recovery from illness symptom and sign disappear completely, ultrasound diagnosis prostate size within normal range, in 1 year without recurrence.
Improvement symptom and sign disappear substantially, and it is normal that ultrasound diagnosis prostate recovers substantially.
Invalid symptom and sign are not improved.
The specific embodiment
Below in conjunction with embodiment, the present invention is described further.
Embodiment
The weight of important source material consists of: 2 parts of Gryllotalpas, 2 parts of Semen Impatientis, 3 parts of Armadillidiums, 4 parts, Natrii Sulfas.
Preparation method: after processing of medical material is qualified by prescription, weighing is assorted, rolls medicine-feeding altogether for fine powder, and even, thin sieve of mistake 80-100 order, packs seal of vessel into.At every turn get it filled 10 grams, powder, includes soak cream cloth in vinegar furnishing pasty state, is pasted into umbilicus, within 24 hours, change dressings once, and within 50 days, be a course for the treatment of.
Case 1: patient thanks so-and-so, man, 40 years old, workman, continuously frequent micturition, urgent micturition, dysurea half a year, over past ten days, self-induction symptom obviously increases the weight of, and nocturia increases, dampness of scrotum; Be diagnosed as chronic prostatitis at local hospital in May, 2011, is in and fails to respond to any medical treatment, in Lai Zhenwo institute in June.According to symptom and sign, examine as type of blood-stasis obstructing in the interior chronic prostatitis, with Drug therapy of the present invention after the course for the treatment of symptom all disappear, it is all normal that B ultrasonic, chemical examination etc. check, follows up a case by regular visits to not recurrence in a year.
Case 2: patient Liu so-and-so, man, 38 years old, because frequent micturition, urgent micturition, dysurea Yue Yu county institute of traditional Chinese medicine are diagnosed as chronic prostatitis, oral Chinese medicine treatment after 30 days without taking a turn for the better.In in August, 2012 Lai Zhenwo institute, examine as type of blood-stasis obstructing in the interior chronic prostatitis, give Drug therapy of the present invention after the course for the treatment of, symptom all disappears, normal through ultrasound diagnosis prostate.Follow up a case by regular visits to not recurrence in a year.
Case 3: patient Zhao so-and-so, man, 47 years old, suffer from chronic prostatitis half a year, multi-treatment is invalid.In July, 2012, Lai Zhenwo institute, was diagnosed as type of blood-stasis obstructing in the interior chronic prostatitis, used Drug therapy of the present invention to fully recover after the course for the treatment of.Follow up a case by regular visits to not recurrence in a year.

Claims (1)

1. treat a Chinese medicine preparation for type of blood-stasis obstructing in the interior chronic prostatitis, the weight of each raw material consists of: 4 parts, 2 parts of Gryllotalpas, 2 parts of Semen Impatientis, 3 parts of Armadillidiums and Natrii Sulfas.
CN201310608246.2A 2013-11-26 2013-11-26 Traditional Chinese medicine preparation for treating chronic prostatitis caused by blood-stasis obstructed in interior Pending CN103638072A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310608246.2A CN103638072A (en) 2013-11-26 2013-11-26 Traditional Chinese medicine preparation for treating chronic prostatitis caused by blood-stasis obstructed in interior

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310608246.2A CN103638072A (en) 2013-11-26 2013-11-26 Traditional Chinese medicine preparation for treating chronic prostatitis caused by blood-stasis obstructed in interior

Publications (1)

Publication Number Publication Date
CN103638072A true CN103638072A (en) 2014-03-19

Family

ID=50243444

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310608246.2A Pending CN103638072A (en) 2013-11-26 2013-11-26 Traditional Chinese medicine preparation for treating chronic prostatitis caused by blood-stasis obstructed in interior

Country Status (1)

Country Link
CN (1) CN103638072A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166355A (en) * 1997-01-11 1997-12-03 徐相廷 Medicine powder for prostatitis
CN1660391A (en) * 2004-12-03 2005-08-31 陈仁德 Preparation of Chinese traditional medicine for treating prostatitis
CN101229238A (en) * 2008-01-07 2008-07-30 包建宇 Chinese traditional medicine preparation for treating prostate disease
CN102949537A (en) * 2011-08-27 2013-03-06 齐建敏 Chinese medicament for treating prostatitis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166355A (en) * 1997-01-11 1997-12-03 徐相廷 Medicine powder for prostatitis
CN1660391A (en) * 2004-12-03 2005-08-31 陈仁德 Preparation of Chinese traditional medicine for treating prostatitis
CN101229238A (en) * 2008-01-07 2008-07-30 包建宇 Chinese traditional medicine preparation for treating prostate disease
CN102949537A (en) * 2011-08-27 2013-03-06 齐建敏 Chinese medicament for treating prostatitis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
冯长青等: "下法在慢性前列腺炎中的应用", 《中医药临床杂志》 *
崔学教: "以瘀阻气虚论治前列腺增生症的思路与方法", 《中国中医基础医学杂志》 *
李传运: "自拟公浙妇归汤治疗慢性前列腺炎65例", 《黑龙江中医药》 *
陈志强等: "慢性前列腺炎的论治进展", 《广州中医药大学学报》 *

Similar Documents

Publication Publication Date Title
CN104001046A (en) Oral traditional Chinese medicine preparation for treating urinary calculus and preparation method thereof
CN103751306B (en) A kind of rheumatism antiinflammation pain-stopping pharmaceutical composition
CN105148024B (en) Chemicals curing piles ointment machin manufacture craft
CN102178817B (en) Chinese medicinal composition for treating multiple lipomas
CN103432551B (en) Externally applied medicine for treating scapulohumeral periarthritis, radiohumeral bursitis and inexplicable ostalgia
CN103638155B (en) The Chinese medicine for outer use for the treatment of talalgia
CN104857091A (en) Traditional Chinese medicine composition for treating renal calculus
CN104055973B (en) Treatment rheumatism bone disease, the Chinese medicinal liniment of arthralgia
CN102872413A (en) Chinese medicinal composition for treating cervical spondylosis
CN102872362A (en) Traditional Chinese medicine for treating chronic cholecystitis
CN103638072A (en) Traditional Chinese medicine preparation for treating chronic prostatitis caused by blood-stasis obstructed in interior
CN104013901A (en) Medicament for treating pelvic inflammation
CN105079290B (en) Compositions purposes in the medicine of preparation treatment acute cholecystitis
CN103432361B (en) Chinese medicinal plaster for treating cervical erosion
CN102225125B (en) Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof
CN101658648B (en) Medicament for treating cervical erosion
CN105343290A (en) Traditional Chinese medicine composition for treating kidney qi deficiency type urolithic stranguria
CN104958631A (en) Pharmaceutical composition for treating kidney stones and preparation method of pharmaceutical composition
CN108853281A (en) A kind of clearing damp removing toxic substances enema fluid and preparation method thereof
CN104001082A (en) Traditional Chinese medicine for treating damp-heat stasis type kidney calculi
CN104740529A (en) Traditional Chinese medicine enema prescription for treating pelvic inflammation
CN104474051A (en) Traditional Chinese medicine for treating arthralgia and preparation method of traditional Chinese medicine
CN104740423A (en) Traditional Chinese medicine for treating rheumatoid arthritis
CN104324078A (en) Traditional Chinese medicine ointment for treating cervical spondylotic radiculopathy
CN104524249B (en) A kind of Chinese medicinal capsule for treating urinary tract infections

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20140319

RJ01 Rejection of invention patent application after publication